Feedback PLC
LSE:FDBK

Watchlist Manager
Feedback PLC Logo
Feedback PLC
LSE:FDBK
Watchlist
Price: 12.25 GBX -2.78%
Market Cap: £5.4m

Feedback PLC
Total Current Liabilities

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Feedback PLC
Total Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Feedback PLC
LSE:FDBK
Total Current Liabilities
£400k
CAGR 3-Years
-15%
CAGR 5-Years
0%
CAGR 10-Years
4%
Renalytix PLC
LSE:RENX
Total Current Liabilities
$4.8m
CAGR 3-Years
-30%
CAGR 5-Years
5%
CAGR 10-Years
N/A
Craneware PLC
LSE:CRW
Total Current Liabilities
$133.4m
CAGR 3-Years
2%
CAGR 5-Years
23%
CAGR 10-Years
16%
Cambridge Cognition Holdings PLC
LSE:COG
Total Current Liabilities
£9.1m
CAGR 3-Years
-15%
CAGR 5-Years
12%
CAGR 10-Years
19%
Doctor Care Anywhere Group PLC
ASX:DOC
Total Current Liabilities
£6.2m
CAGR 3-Years
-9%
CAGR 5-Years
10%
CAGR 10-Years
N/A
P
Physitrack PLC
STO:PTRK
Total Current Liabilities
€4.8m
CAGR 3-Years
-12%
CAGR 5-Years
5%
CAGR 10-Years
N/A
No Stocks Found

Feedback PLC
Glance View

Market Cap
5.4m GBX
Industry
Health Care

Feedback Plc operates as an investing company, which seeks to acquire a direct interest in one or more companies in the technology sector. The principal activity of the Company is the development and commercialization of its technologies, including Bleepa, the image-based communication platform for frontline clinicians; CareLocker, the patientcentric cloud architecture, and Bleepa Box, store and forward technology. The company offers TexRAD, which provides radiologists, clinicians and medical researchers with a non-invasive imaging biomarker. Its TexRAD’s algorithm extracts and quantifies texture features in pre-existing medical images. These texture features are used to demonstrate diagnostic, prognostic and predictive intelligence in scientific research with particular focus in oncology. The company offers Cadran, a suite of picture archiving storage, management and display system for medical images. The company also provides consultancy services for medical image management within organizations. The company offers TexRAD Lung, a software tool for the analysis of lung cancer.

FDBK Intrinsic Value
2.96 GBX
Overvaluation 76%
Intrinsic Value
Price GBX12.25

See Also

What is Feedback PLC's Total Current Liabilities?
Total Current Liabilities
400k GBP

Based on the financial report for Nov 30, 2025, Feedback PLC's Total Current Liabilities amounts to 400k GBP.

What is Feedback PLC's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
4%

Over the last year, the Total Current Liabilities growth was -49%. The average annual Total Current Liabilities growth rates for Feedback PLC have been -15% over the past three years , and 4% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett